| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |